- Home
- MKSI vs GMED Comparison
MKSI vs GMED Comparison
Compare MKSI & GMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MKSI
- GMED
- Stock Information
- Founded
- MKSI 1961
- GMED 2003
- Country
- MKSI United States
- GMED United States
- Employees
- MKSI N/A
- GMED N/A
- Industry
- MKSI Industrial Machinery/Components
- GMED Medical/Dental Instruments
- Sector
- MKSI Industrials
- GMED Health Care
- Exchange
- MKSI Nasdaq
- GMED Nasdaq
- Market Cap
- MKSI N/A
- GMED 11.6B
- IPO Year
- MKSI 1999
- GMED 2012
- Fundamental
- Price
- MKSI $111.11
- GMED $88.11
- Analyst Decision
- MKSI Strong Buy
- GMED Buy
- Analyst Count
- MKSI 11
- GMED 13
- Target Price
- MKSI $143.00
- GMED $95.42
- AVG Volume (30 Days)
- MKSI 701.3K
- GMED 1.0M
- Earning Date
- MKSI 02-05-2025
- GMED 02-20-2025
- Dividend Yield
- MKSI 0.79%
- GMED N/A
- EPS Growth
- MKSI N/A
- GMED N/A
- EPS
- MKSI 0.45
- GMED 0.67
- Revenue
- MKSI $3,544,000,000.00
- GMED $2,478,596,000.00
- Revenue This Year
- MKSI $0.41
- GMED $62.39
- Revenue Next Year
- MKSI $8.06
- GMED $6.71
- P/E Ratio
- MKSI $245.43
- GMED $131.18
- Revenue Growth
- MKSI N/A
- GMED 102.10
- 52 Week Low
- MKSI $97.54
- GMED $49.33
- 52 Week High
- MKSI $147.40
- GMED $90.48
- Technical
- Relative Strength Index (RSI)
- MKSI 53.46
- GMED 69.74
- Support Level
- MKSI $105.34
- GMED $86.28
- Resistance Level
- MKSI $116.63
- GMED $90.48
- Average True Range (ATR)
- MKSI 3.14
- GMED 1.86
- MACD
- MKSI 0.50
- GMED 0.46
- Stochastic Oscillator
- MKSI 61.53
- GMED 73.98
About GMED Globus Medical Inc.
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include advanced computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States.